SpyGlass Pharma Acquires Advanced Vision Science, Inc. (AVS), Securing Scalable Commercial IOL Supply and Accelerating Lens Portfolio Expansion Capability

BIM-IOL SystemPositive

AI Analysis

Summary

SpyGlass Pharma acquired Advanced Vision Science, Inc. for approximately $13 million in cash, securing scalable IOL manufacturing capacity and supply for its Phase 3 BIM-IOL System trials.

Clinical Trial Data

Phase

Phase 3

Importance:6/10

Sentiment:

0.60

acquisitionintraocular lensmedical devicemanufacturingophthalmic

Related Companies

$SGP

Read the original article

Published by GlobeNewswire Pharma on October 1, 2026 12:00 PM

Read Original